English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 47121/50987 (92%)
造訪人次 : 13816173      線上人數 : 264
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於CCUR管理 到手機版


    請使用永久網址來引用或連結此文件: https://irlib.pccu.edu.tw/handle/987654321/44645


    題名: Circulating Chemerin Levels, but not the RARRES2 Polymorphisms, Predict the Long-Term Outcome of Angiographically Confirmed Coronary Artery Disease
    作者: Er, LK (Er, Leay Kiaw)
    Hsu, LA (Hsu, Lung-An)
    Juang, JMJ (Juang, Jyh-Ming Jimmy)
    Chiang, FT (Chiang, Fu-Tien)
    Teng, MS (Teng, Ming-Sheng)
    Tzeng, IS (Tzeng, I-Shiang)
    Wu, S (Wu, Semon)
    Lin, JF (Lin, Jeng-Feng)
    Ko, YL (Ko, Yu-Lin)
    貢獻者: 生命科學系
    關鍵詞: CARDIOVASCULAR STRESS
    ADIPOKINE CHEMERIN
    PLASMA CHEMERIN
    INFLAMMATION
    OBESITY
    RISK
    BIOMARKERS
    DYSFUNCTION
    EXPRESSION
    LINK
    日期: 2019-03-01
    上傳時間: 2019-06-25 13:10:53 (UTC+8)
    摘要: Chemerin, a novel adipokine, has been associated with metabolic, inflammatory, and atherosclerotic diseases. We aimed to determine the genetic basis of chemerin levels by conducting a genome-wide association study (GWAS) and to investigate the role of RARRES2 polymorphisms and circulating chemerin levels in the long-term outcome of coronary artery disease (CAD). A total of 2197 participants from the Taiwan Biobank (TWB) were recruited for the GWAS analysis, and 481 patients with angiographically confirmed CAD were enrolled for long-term outcome analysis. One locus of genome-wide significance with a single independent association signal was identified in the GWAS for chemerin levels with the peak association at the RARRES2 gene promoter region polymorphism rs3735167 (p = 2.35 x 10(-21)). In the CAD population, borderline significance was noted between RARRES2 polymorphisms and chemerin levels, whereas high chemerin levels were associated with obesity, female sex, diabetes mellitus, hypertension, current smoking, high platelet and leukocyte counts, anemia, impaired renal function, high C-reactive protein (CRP) levels, and multi-vessel disease. Kaplan-Meier survival curves indicated that the patients with high chemerin and CRP levels, but not those with RARRES2 polymorphisms, had a lower survival rate and higher combined cerebral and cardiovascular event rates. Combined chemerin and CRP levels further revealed a stepwise increase in poor clinical outcomes from low- to high-risk subgroups. In conclusion, rs3735167 is the lead RARRES2 polymorphism for chemerin levels in Taiwanese. Chemerin levels, but not the rs3735167 genotypes, predicted the long-term outcome of CAD, especially when combined with CRP levels.
    關聯: Int. J. Mol. Sci. 2019, 20(5), 1174
    顯示於類別:[生命科學系] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML228檢視/開啟


    在CCUR中所有的資料項目都受到原著作權保護.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋